BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16254334)

  • 21. Regulation of angiogenesis in malignancies associated with Epstein-Barr virus and Kaposi's sarcoma-associated herpes virus.
    Sakakibara S; Tosato G
    Future Microbiol; 2009 Sep; 4(7):903-17. PubMed ID: 19722843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus (EBV)-encoded RNA 2 (EBER2) but not EBER1 plays a critical role in EBV-induced B-cell growth transformation.
    Wu Y; Maruo S; Yajima M; Kanda T; Takada K
    J Virol; 2007 Oct; 81(20):11236-45. PubMed ID: 17686859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas.
    Feng WH; Cohen JI; Fischer S; Li L; Sneller M; Goldbach-Mansky R; Raab-Traub N; Delecluse HJ; Kenney SC
    J Natl Cancer Inst; 2004 Nov; 96(22):1691-702. PubMed ID: 15547182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
    Wen W; Iwakiri D; Yamamoto K; Maruo S; Kanda T; Takada K
    J Virol; 2007 Jan; 81(2):1037-42. PubMed ID: 17079287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A.
    Seo JS; Cho NY; Kim HR; Tsurumi T; Jang YS; Lee WK; Lee SK
    Oncol Rep; 2008 Jan; 19(1):93-8. PubMed ID: 18097580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies.
    Westphal EM; Blackstock W; Feng W; Israel B; Kenney SC
    Cancer Res; 2000 Oct; 60(20):5781-8. PubMed ID: 11059774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186.
    Bhende PM; Seaman WT; Delecluse HJ; Kenney SC
    J Virol; 2005 Jun; 79(12):7338-48. PubMed ID: 15919888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.
    Kalla M; Hammerschmidt W
    Eur J Cell Biol; 2012 Jan; 91(1):65-9. PubMed ID: 21450364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EBV lytic infection enhances transformation of B-lymphocytes infected with EBV in the presence of T-lymphocytes.
    Katsumura KR; Maruo S; Takada K
    J Med Virol; 2012 Mar; 84(3):504-10. PubMed ID: 22246839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suberoylanilide hydroxamic acid induces viral lytic cycle in Epstein-Barr virus-positive epithelial malignancies and mediates enhanced cell death.
    Hui KF; Chiang AK
    Int J Cancer; 2010 May; 126(10):2479-89. PubMed ID: 19816947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium mobilization is responsible for Thapsigargin induced Epstein Barr virus lytic reactivation in
    Hoji A; Xu S; Bilben H; Rowe DT
    Heliyon; 2018 Nov; 4(11):e00917. PubMed ID: 30480154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strong cross-talk between angiogenesis and EBV: do we need different treatment approaches in lymphoma cases with EBV and/or high angiogenic capacity.
    Paydas S
    Med Oncol; 2012 Sep; 29(3):2159-65. PubMed ID: 21948392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Epstein-Barr virus BRRF1 protein, Na, induces lytic infection in a TRAF2- and p53-dependent manner.
    Hagemeier SR; Barlow EA; Kleman AA; Kenney SC
    J Virol; 2011 May; 85(9):4318-29. PubMed ID: 21325409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transforming growth factor beta-1 (TGF-beta 1) released by an Epstein-Barr virus (EBV) positive spontaneous lymphoblastoid cell line from a patient with Kostmann's congenital neutropenia inhibits the growth of normal committed haemopoietic progenitors in vitro.
    Corcione A; Roncella S; Cutrona G; Mori PG; Ferrarini M; Pistoia V
    Br J Haematol; 1993 Dec; 85(4):684-91. PubMed ID: 7918030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dendrosomal nanocurcumin prevents EBV-associated cell transformation by targeting the lytic cycle genes of the Epstein-Barr virus in the generation of lymphoblastoid cell line.
    Cheragh M; Sadeghizadeh M; Pouriayevali MH; Parsania M
    Iran J Basic Med Sci; 2023; 26(10):1220-1226. PubMed ID: 37736518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus lytic gene BNRF1 promotes B-cell lymphomagenesis via IFI27 upregulation.
    Sagou K; Sato Y; Okuno Y; Watanabe T; Inagaki T; Motooka Y; Toyokuni S; Murata T; Kiyoi H; Kimura H
    PLoS Pathog; 2024 Feb; 20(2):e1011954. PubMed ID: 38300891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dasatinib exacerbates splenomegaly of mice inoculated with Epstein-Barr virus-infected lymphoblastoid cell lines.
    Kotaki R; Kawashima M; Yamamoto Y; Higuchi H; Nagashima E; Kurosaki N; Takamatsu M; Kikuti YY; Imadome KI; Nakamura N; Kotani A
    Sci Rep; 2020 Mar; 10(1):4355. PubMed ID: 32152351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr Virus- (EBV-) Immortalized Lymphoblastoid Cell Lines (LCLs) Express High Level of CD23 but Low CD27 to Support Their Growth.
    Yap HY; Siow TS; Chow SK; Teow SY
    Adv Virol; 2019; 2019():6464521. PubMed ID: 31049064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular gene expression that correlates with EBER expression in Epstein-Barr Virus-infected lymphoblastoid cell lines.
    Gregorovic G; Bosshard R; Karstegl CE; White RE; Pattle S; Chiang AK; Dittrich-Breiholz O; Kracht M; Russ R; Farrell PJ
    J Virol; 2011 Apr; 85(7):3535-45. PubMed ID: 21248031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation analysis of the EBV-lymphoblastoid cell line cautions their use as antigen-presenting cells.
    Tan Q; Ku W; Zhang C; Heyilimu P; Tian Y; Ke Y; Lu Z
    Immunol Cell Biol; 2018 Feb; 96(2):204-211. PubMed ID: 29363169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.